Skip to main content
. 2018 Jul 17;20(8):857–870. doi: 10.1016/j.neo.2018.06.008

Figure 1.

Figure 1

DNA damaging drugs promote ETV7 transcriptional activation. RT-qPCR analysis of ETV7 expression upon different chemotherapeutics treatment in breast cancer-derived MCF7 (A) and MDA-MB-231 cells (B), and in healthy donor-derived lymphocytes (C). Bars represent average Fold Changes relative to the untreated condition and standard deviations of at least three biological replicates. * = P-value <0.01.